Transthoracic drug delivery device

• US 6,251,079 B1
• Filed: 09/30/1998
• Issued: 06/26/2001
• Est. Priority Date: 09/30/1998
• Status: Expired due to Fees

• Current Assignee: C.R. Bard, Inc. (Becton, Dickinson & Co)
• Original Assignee: C.R. Bard, Inc. (Becton, Dickinson & Co)
• Inventors: Gambale, Richard A., Forcucci, Stephen J., Cafferata, Robert, Choh, Richard T.
• Primary Examiner(s): KENNEDY, SHARON E
• Application Number:
  US09/164,164
• Time in Patent Office: 1,000 Days
• Field of Search: 600/486, 600/487, 600/468, 600/508, 607/120, 604/264
• US Class Current: 600/486
• CPC Class Codes: A61B 2017/00247 Making holes in the wall of the heart, e.g. laser Myocardial revascularization
• CPC Class Codes: A61B 2018/00392 Transmyocardial revascularisation
• CPC Class Codes: A61M 2025/0002 with a pressure sensor at the distal end
• CPC Class Codes: A61M 2025/0003 having an additional lumen transmitting fluid pressure to the outside for measurement
• CPC Class Codes: A61M 2025/0034 characterized by elements which are assembled, connected or fused, e.g. splittable tubes, outer sheaths creating lumina or separate cores making of catheters A61M25/0009
• CPC Class Codes: A61M 2025/0036 with more than four lumina
• CPC Class Codes: A61M 2025/0086 the needles having bent tips, i.e. the needle distal tips are angled in relation to the longitudinal axis of the catheter
• CPC Class Codes: A61M 2210/10 Trunk
• CPC Class Codes: A61M 2230/005 Parameter used as control input for the apparatus
• CPC Class Codes: A61M 25/0068 Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
• CPC Class Codes: A61M 25/008 Strength or flexibility characteristics of the catheter tip
• CPC Class Codes: A61M 25/0084 being one or more injection needles
• CPC Class Codes: A61M 25/0133 Tip steering devices
• CPC Class Codes: A61M 25/0147 with movable mechanical means, e.g. pull wires

Abstract

The present invention provides a transthoracic drug delivery device that utilizes pressure to determine the precise location of the distal tip of the delivery tube of the device to insure that therapeutic substances are ejected into the myocardium and not dissipated in unintended tissue locations. In one embodiment the drug delivery device comprises a pressure sensing tube mounted in parallel to a drug delivery tube wherein the tubes are staggered so that the pressure tube extends beyond the delivery tube. When the myocardium is penetrated by the tubes, advancement into the heart and penetration into the left ventricle by the pressure sensing tube results in a pressure increase that indicates to the physician that the drug delivery tube, by its placement relative to the pressure sensing tube is still in the myocardium and, thus, prepared to deliver the drug. In another embodiment, a steerable syringe is provided so that multiple sites in the myocardium can be treated with a therapeutic substance with only one penetration into the heart. Once the delivery tube of the syringe penetrates the left ventricle, its distal tip can be deflected back toward the endocardial surface and the tube withdrawn proximally to cause penetration of the tip into the myocardium. A pressure sensor mounted to the tube indicates, by a measured drop in pressure that the myocardium has been penetrated. The therapeutic substance is ejected into the myocardium and the device is then backed out of the tissue by advancing the syringe in a distal direction. The deflectable tip can be adjusted to a different deflection angle and the delivery tube rotated to make available a circular array of points that may be accessed by the syringe.

Claims

1. A transthoracic drug delivery device comprising:

a pressure sensing tube and a drug delivery tube joined to the pressure sensing tube in a parallel relationship, but staggered so that one tube extends distally beyond the other by a known distance and at least the distally oriented tube has a sharpened distal tip configured to penetrate tissue;

wherein the pressure sensing tube extends distally beyond the drug delivery tube.

2. A transthoracic drug delivery device as defined in claim 1 wherein the known distance between the ends of the staggered tubes is less than the thickness of a subject patient'"'"'s myocardium.

3. A transthoracic drug delivery device comprising:

a pressure sensing tube and a drug delivery tube joined to the pressure sensing tube in a parallel relationship, but staggered so that one tube extends distally beyond the other by a known distance and at least the distally oriented tube has a sharpened distal tip configured to penetrate tissue, and

a pressure monitor joined to the pressure sensing tube and a source of a therapeutic substance joined to the drug delivery tube.

4. A transthoracic drug delivery device comprising:

a pressure sensing tube and a plurality of drug delivery tubes joined to the pressure sensing tube in a parallel relationship, but staggered so that one tube extends distally beyond the other by a known distance and at least the distally oriented tube has a sharpened distal tip configured to penetrate tissue.

5. A method of delivering a therapeutic substance to the myocardium comprising:

providing a delivery device comprised of a pressure sensing tube joined to at least one drug delivery tube maintained in parallel but staggered so that the pressure tube extends distally beyond the drug delivery tube by a known distance that is less than the thickness of the myocardium and at least the distally oriented tube has a sharpened distal tip configured to penetrate tissue;

transthoracically accessing the heart;

inserting the tubes into the heart;

monitoring the pressure sensed by the tube while moving the device further into the heart;

stopping advancement of the device into the heart when a dramatic pressure increase is noted indicating pressure sensing tube has entered the ventricle and the delivery tube id within the myocardium;

ejecting a quantity of a therapeutic substance from the delivery tube into the myocardium.